RHYTHM PHARMACEUTICALS, INC. (RYTM) Free cash flow 2016–2025
RHYTHM PHARMACEUTICALS, INC. (RYTM) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$116.6MFY2025 · since FY2016: -$24.3M → -$116.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$116.6M | -2.4% |
| FY2024 | -$113.9M | +16.4% |
| FY2023 | -$136.2M | +21.6% |
| FY2022 | -$173.7M | -18.6% |
| FY2021 | -$146.4M | -19.8% |
| FY2020 | -$122.2M | +3.1% |
| FY2019 | -$126.1M | -100.9% |
| FY2018 | -$62.8M | -112.1% |
| FY2017 | -$29.6M | -21.9% |
| FY2016 | -$24.3M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More RYTM financial trends
RYTM RevenueRYTM Net incomeRYTM Net marginRYTM Gross profitRYTM Gross marginRYTM Operating incomeRYTM Operating marginRYTM Operating cash flowRYTM Capital expendituresRYTM Return on equityRYTM Stock buybacksRYTM Dividends paidRYTM Total assetsRYTM Total liabilitiesRYTM Shareholders’ equityRYTM overview →